TY - JOUR
T1 - End-Stage renal disease and 30-day mortality for adults with and without COVID-19
AU - Harrison, Stephanie L
AU - Buckley, Benjamin J R
AU - Fazio-Eynullayeva, Elnara
AU - Underhill, Paula
AU - Lane, Deirdre A
AU - Lip, Gregory Y H
PY - 2021/1
Y1 - 2021/1
N2 - Emerging evidence suggests that people with chronic kidney disease have a higher risk of severe infection with coronavirus disease 2019 (COVID-19) [1]. Furthermore, acute kidney injury is common amongst patients hospitalised with COVID-19 compared to historical controls (56.9% vs. 25.1%) [2]. An estimated 726,000 people in the United States (US) are affected by end-stage renal disease (ESRD), and one-year mortality for people with ESRD who receive dialysis is approximately 20–25% [3]. Reports from China, England, Italy and France have suggested between 9% and 27% of patients with ESRD who tested positive for COVID-19 died, compared to 4% globally as of July 2020 [4]. The extent to which COVID-19 may worsen outcomes for people with ESRD is unclear. Therefore, the objective of this study was to compare 30-day mortality for people with ESRD and COVID-19 (cases) to matched people with ESRD before the COVID-19 pandemic (historical controls).
AB - Emerging evidence suggests that people with chronic kidney disease have a higher risk of severe infection with coronavirus disease 2019 (COVID-19) [1]. Furthermore, acute kidney injury is common amongst patients hospitalised with COVID-19 compared to historical controls (56.9% vs. 25.1%) [2]. An estimated 726,000 people in the United States (US) are affected by end-stage renal disease (ESRD), and one-year mortality for people with ESRD who receive dialysis is approximately 20–25% [3]. Reports from China, England, Italy and France have suggested between 9% and 27% of patients with ESRD who tested positive for COVID-19 died, compared to 4% globally as of July 2020 [4]. The extent to which COVID-19 may worsen outcomes for people with ESRD is unclear. Therefore, the objective of this study was to compare 30-day mortality for people with ESRD and COVID-19 (cases) to matched people with ESRD before the COVID-19 pandemic (historical controls).
KW - Renal disease
KW - Mortality
KW - COVID-19
KW - Comorbidity
KW - Chronic kidney disease
UR - http://www.scopus.com/inward/record.url?scp=85096873532&partnerID=8YFLogxK
U2 - 10.1016/j.ejim.2020.11.003
DO - 10.1016/j.ejim.2020.11.003
M3 - Letter
C2 - 33187792
AN - SCOPUS:85096873532
SN - 0953-6205
VL - 83
SP - 93
EP - 95
JO - European Journal of Internal Medicine
JF - European Journal of Internal Medicine
ER -